ORAGENICS, INC. Common Stock, Value, Issued
ORAGENICS, INC. (OGEN) had Common Stock, Value, Issued of $4.51 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $4.51K.
- 2026-03-31: Common Stock, Value, Issued $4.38K.
- 2025-12-31: Common Stock, Value, Issued $4.27K.
- 2025-09-30: Common Stock, Value, Issued $4.13K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $4.51K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.38K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $4.27K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.13K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $823.00 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $21.48K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $419.00 10-K · filed 2026-03-16 | $12.57K 10-K · filed 2025-03-14 |
| 2024-09-30 | $9.39K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $5.58K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $4.48K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.08K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $2.55K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.02K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $2.02K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.02K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $117.31K 10-Q/A · filed 2023-04-14 | |
| 2022-06-30 | $116.39K 10-Q/A · filed 2023-04-14 | |
| 2022-03-31 | $116.39K 10-Q/A · filed 2023-04-14 | |
| 2021-12-31 | $2.00K 10-K · filed 2023-04-17 | $116.39K 10-K · filed 2022-03-24 |
| 2021-09-30 | $116.39K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $116.19K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $115.64K 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $91.77K 10-K/A · filed 2022-07-29 | |
| 2020-09-30 | $61.01K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $55.36K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $46.13K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $46.13K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $46.13K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $46.13K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $46.11K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $29.43K 10-K · filed 2020-03-04 | |
| 2018-09-30 | $18.42K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $6.10K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $5.19K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $4.93K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $49.27K 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $49.27K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $49.27K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.91K 10-K · filed 2018-02-16 | $49.11K 10-K · filed 2017-02-27 |
| 2016-09-30 | $49.11K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $49.11K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $40.06K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $39.86K 10-K · filed 2017-02-27 | |
| 2015-09-30 | $36.48K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $36.38K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $36.38K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $36.18K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $36.18K 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $36.18K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $36.13K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $35.99K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $30.17K 10-Q · filed 2013-10-25 | |
| 2013-06-30 | $27.51K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $27.49K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $27.38K 10-K · filed 2014-02-28 | |
| 2012-09-30 | $27.20K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $16.57K 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $12.18K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $5.89K 10-K · filed 2013-03-26 | |
| 2011-09-30 | $5.68K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $5.68K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $5.66K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |